Quick Answer
Shuttle Pharmaceuticals Holdings, Inc. reported Total Assets of $10.48 million for the year ending 2025.
- Shuttle Pharmaceuticals Holdings, Inc. showed an increase of +318.0% in Total Assets from 2024 to 2025.
- This data is from Shuttle Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $9.38 million | Q1 2023: $10.44 million | Q2 2023: $8.84 million | Q3 2023: $7.38 million | Q1 2024: $4.75 million | Q2 2024: $2.81 million | Q3 2024: $673.6 thousand | Q1 2025: $5.31 million | Q2 2025: $5.50 million | Q3 2025: $3.54 million.
- Over the full 5 years of available data (2021 to 2025), Shuttle Pharmaceuticals Holdings, Inc.'s Total Assets has grown by 1,507.6%.
- Historical annual values: Fiscal year 2025: $10.48 million | Fiscal year 2024: $2.51 million | Fiscal year 2023: $5.95 million | Fiscal year 2022: $8.65 million | Fiscal year 2021: $651.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: